233 related articles for article (PubMed ID: 32409578)
1. Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors.
Morimoto K; Suzuki N; Tanida I; Kakuta S; Furuta Y; Uchiyama Y; Hanada K; Suzuki Y; Yamaji T
J Biol Chem; 2020 Jul; 295(28):9490-9501. PubMed ID: 32409578
[TBL] [Abstract][Full Text] [Related]
2. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
3. Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression.
Shin IS; Ishii S; Shin JS; Sung KI; Park BS; Jang HY; Kim BW
BMB Rep; 2009 May; 42(5):310-4. PubMed ID: 19470247
[TBL] [Abstract][Full Text] [Related]
4. Shiga toxin binding to glycolipids and glycans.
Gallegos KM; Conrady DG; Karve SS; Gunasekera TS; Herr AB; Weiss AA
PLoS One; 2012; 7(2):e30368. PubMed ID: 22348006
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
[TBL] [Abstract][Full Text] [Related]
6. Glycolipid binding preferences of Shiga toxin variants.
Karve SS; Weiss AA
PLoS One; 2014; 9(7):e101173. PubMed ID: 24983355
[TBL] [Abstract][Full Text] [Related]
7. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
Zumbrun SD; Hanson L; Sinclair JF; Freedy J; Melton-Celsa AR; Rodriguez-Canales J; Hanson JC; O'Brien AD
Infect Immun; 2010 Nov; 78(11):4488-99. PubMed ID: 20732996
[TBL] [Abstract][Full Text] [Related]
8. Shiga toxin and its use in targeted cancer therapy and imaging.
Engedal N; Skotland T; Torgersen ML; Sandvig K
Microb Biotechnol; 2011 Jan; 4(1):32-46. PubMed ID: 21255370
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
[TBL] [Abstract][Full Text] [Related]
10. Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.
Steil D; Schepers CL; Pohlentz G; Legros N; Runde J; Humpf HU; Karch H; Müthing J
J Lipid Res; 2015 Dec; 56(12):2322-36. PubMed ID: 26464281
[TBL] [Abstract][Full Text] [Related]
11. One of the two N-glycans on the human Gb3/CD77 synthase is essential for its activity and allosterically regulates its function.
Mikolajczyk K; Sikora M; Hanus C; Kaczmarek R; Czerwinski M
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):36-41. PubMed ID: 35671609
[TBL] [Abstract][Full Text] [Related]
12. Primary Human Colon Epithelial Cells (pHCoEpiCs) Do Express the Shiga Toxin (Stx) Receptor Glycosphingolipids Gb3Cer and Gb4Cer and Are Largely Refractory but Not Resistant towards Stx.
Detzner J; Püttmann C; Pohlentz G; Humpf HU; Mellmann A; Karch H; Müthing J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576167
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis.
Yamaji T; Nishikawa K; Hanada K
J Biol Chem; 2010 Nov; 285(46):35505-18. PubMed ID: 20837469
[TBL] [Abstract][Full Text] [Related]
14. The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene. A clue to the solution of the P1/P2/p puzzle.
Iwamura K; Furukawa K; Uchikawa M; Sojka BN; Kojima Y; Wiels J; Shiku H; Urano T; Furukawa K
J Biol Chem; 2003 Nov; 278(45):44429-38. PubMed ID: 12888565
[TBL] [Abstract][Full Text] [Related]
15. Identification of SYS1 as a Host Factor Required for Shiga Toxin-Mediated Cytotoxicity in Vero Cells.
Sakuma C; Sekizuka T; Kuroda M; Hanada K; Yamaji T
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066520
[TBL] [Abstract][Full Text] [Related]
16. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e.
Keusch GT; Jacewicz M; Acheson DW; Donohue-Rolfe A; Kane AV; McCluer RH
Infect Immun; 1995 Mar; 63(3):1138-41. PubMed ID: 7868240
[TBL] [Abstract][Full Text] [Related]
17. Shiga Toxin (Stx) Classification, Structure, and Function.
Melton-Celsa AR
Microbiol Spectr; 2014 Aug; 2(4):EHEC-0024-2013. PubMed ID: 25530917
[TBL] [Abstract][Full Text] [Related]
18. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells.
Betz J; Bauwens A; Kunsmann L; Bielaszewska M; Mormann M; Humpf HU; Karch H; Friedrich AW; Müthing J
Biol Chem; 2012 Mar; 393(3):133-47. PubMed ID: 22718629
[TBL] [Abstract][Full Text] [Related]
19. CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.
Pacheco AR; Lazarus JE; Sit B; Schmieder S; Lencer WI; Blondel CJ; Doench JG; Davis BM; Waldor MK
mBio; 2018 Jun; 9(3):. PubMed ID: 29921669
[TBL] [Abstract][Full Text] [Related]
20. Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor.
Johansson K; Willysson A; Kristoffersson AC; Tontanahal A; Gillet D; Ståhl AL; Karpman D
Front Cell Infect Microbiol; 2020; 10():212. PubMed ID: 32523894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
